key: cord-0727257-otf7mxwp
authors: Schiavon, Riccardo; Casazza, Giovanni; Cogliati, Chiara
title: Right Ventricular Longitudinal Strain: a new prognostic tool for COVID-19?
date: 2020-07-04
journal: JACC Cardiovasc Imaging
DOI: 10.1016/j.jcmg.2020.06.019
sha: a725d8cccc2a57b6e6fc793fccea69afb138915a
doc_id: 727257
cord_uid: otf7mxwp

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

We have read with interest the paper by Yuman Li et al. regarding the prognostic value of right ventricular longitudinal strain in patients with COVID-19 [1] . As the morbidity and mortality of the ongoing pandemic coronavirus disease 2019 (COVID-19) are posing a serious threat to healthcare systems all over the world, the urge to find prognostic factors to better stratify patients and offer adequate level of medical assistance to everyone is of the utmost importance.

However, we have some remarks, both from a clinical and methodological point of view.

Firstly, the Authors report a remarkable incidence of deep vein thrombosis (DVT) (41% of the population), with surprisingly no documented cases of pulmonary embolism (PE). We wonder how was the diagnosis of DVT and PE performed (i.e., there was an extensive screening protocol for both DVT and PE?) and how these findings were interpreted by the authors. Do the authors think that eventually undiagnosed or subclinical PE events may explain right ventricle echocardiographic parameters modification in bad prognosis patients?

A methodological remark regards the significant variability of the timing of the echocardiographic study, with an IQ range of 3-10 days between admission and examination. We wonder if this could have affected the results, possibly increasing the prognostic values of RV dysfunction for tests performed during the detrimental phase of ARDS. Moreover, it should be stated if echocardiography was performed during invasive or non-invasive ventilation or in oxygen, as it is well known how ventilation itself could significantly modify echocardiographic parameters, including right ventricular longitudinal strain [2] . This could represent a potential bias, as severe patients were more likely to undergo ventilation support, a condition possibly making RV echo parameters just innocent bystanders.

Finally, the proposed cut-off values for RVLS, TAPSE and RVFAC are largely within the normal range in heathy subjects. We wonder how the authors interpreted the biologic plausibility of their findings. Is it possible to speculate that the active phase of the disease leads to a form of

Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19

Moderate and severe acute respiratory distress syndrome: Hemodynamic and cardiac effects of an open lung strategy with recruitment maneuver analyzed using echocardiography